Drug Profile
Research programme: stem cell modulators - Actium
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Actium Research
- Class Small molecules
- Mechanism of Action Stem cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Canada
- 30 May 2012 Research programme: stem cell modulators is available for licensing as of 30 May 2012. www.actiumresearch.com
- 30 May 2012 Early research in Cancer in Canada (unspecified route)